138 Infos zu Hans Schambye

40 Aktuelle Nachrichten

· ... today announced that Hans Schambye, the Company's Chief Executive Officer, will be presenting on Tuesday, September 28, at 8:40 AM ...

Att en amerikansk läkemedelsjätte lägger ett miljardbud på ett svenskt bioteknikföretag är en affär helt i tiden. Livsvetenskap – life science – är hett bland...

Gastrotech Pharma A/S announced today that Dr. Hans T. Schambye has been appointed as its Chief Executive Officer.

Gastrotech Announces the Appointment of Dr. Hans Schambye as Chief Executive Officer. Copenhagen, Denmark (ots/PRNewswire) ...

10 Profile in Sozialen Netzwerken

Se Hans Schambyes professionel profil på LinkedIn. LinkedIn er verdens største erhvervsnetværk, der hjælper fagfolk som Hans Schambye med at finde interne ... Es fehlt: london ‎cassell

Hans Schambyes berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Hans Schambye dabei ...

4 Hobbys & Interessen

Galecto, the leading developer of galectin modulators has successfully closed a €79 million series C financing co-led by Ysios Capital and OrbiMed.

Recent bibliographic sampling of Hans Schambye patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title): ...

· Hans Schambye, CEO of Galecto, said: "We are delighted to once again count on Novo Seeds' support and look forward to continue working with this ...

Step Pharma, a biotech company developing novel drugs for autoimmune diseases, has appointed Andrew Parker, Ph.D., as CEO.

1 Firmen-Mitarbeiter

Hans Schambye, (Chairman). CEO · Adam Steensberg, Chief Medical & Development Officer · Alejandra Mørk, CEO · Henrik Blou,

1 Persönliche Webseiten

He gained a PhD at the Imperial Cancer Research Fund London and was subsequently ... Hans Schambye is a seasoned biotech entrepreneur with extensive ...

3 Infos zur Ausbildung

author = "Alison Mackinnon and Chen, {Wei Sheng} and Hakon Leffler and Noorjahan Panjwani and Hans Schambye and Tariq Sethi and Nilsson, {Ulf J.}",.

AstraZeneca. We K:F, Drug development in small biotech. Fibrosis - an orphan indication, UN and Hans Schambye, ceo Galecto Biotech AB.

... Monique and Pieters, {Roland J.} and Tariq Sethi and Hans Schambye and Stina Oredsson and Hakon Leffler and Helen Blanchard and Nilsson, {Ulf J.}",.

2 Bücher zum Namen

Jeg husker også Hans Schambye Espensen med M/jagten KOMETEN, og Peter Hansen (Snedker) med M/jagt PRØVEN, samt M/jagt FREYA, N.P. Andersen, ...

... and Applications of Galectin Modulators in Human Health Alison Mackinnon, Wei-Sheng Chen, Hakon Leffler, Noorjahan Panjwani, Hans Schambye, Tariq Sethi, ...

4 Dokumente

· Dr. Hans Schambye,. Dr. Hans Schambye. Galecto Biotech ApS, COBIS, Ole Maaloes vej 3, Copenhagen N, Denmark.

... Neil C. Henderson, Fredrik R. Zetterberg, Ulf J. Nilsson, Hakon Leffler, Paul Ford, Anders Pedersen, Lise Gravelle, Susan Tantawi, Hans Schambye, ...

Hans Schambye. x. Hans Schambye. Search for articles by this author. , Alison C. MacKinnon. x. Alison C. MacKinnon. Search for articles by this author.

· Dr. Hans Schambye, President and Chief Executive Officer of Galecto, commented, “We are very excited to have demonstrated proof of principle ...

3 Allgemeine Veröffentlichungen

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art...

· micro-environment remains unaddressed and LOXL2 inhibition could be disease modifying,” said Dr. Hans Schambye, CEO of Galecto.

Over the last decade, the family of galectin proteins has been identified as key regulators of important biological processes. They bind β- d-galactopyranoside...

1 Video- & Audioinhalte

· [REUPLOADING] The Danish biotech industry has so much to offer! We visited the city of ...Dauer: 4:28Gepostet:

3 Meinungen & Artikel

Galecto Biotech AB, 2200, Copenhagen N, Denmark. Fredrik Zetterberg; & Hans Schambye. Department of Cellular and Molecular Medicine, ...

By targeting a sugar-binding protein, a Swedish startup hopes to provide new lung fibrosis treatments.

62 Webfunde aus dem Netz

View Hans Schambye's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Hans Schambye discover ...

Talks at the Square with Hans Schambye. eventbrite.dk · 2 · Like Comment. Share. Copy; LinkedIn; Facebook; Twitter. To view or add a comment, sign in ...

Hans Schambye. CEO at Galecto Biotech AB. Follow. 3 comments. article-comment__guest-image. Sign in to leave your comment ...

... demonstrate the importance of galectin-3 as an anti-fibrosis target,” said Hans Schambye, M.D., Ph.D, chief executive officer, Galecto Biotech.

Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development. Previously, Hans served as the Chief Executive ...Biography: Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development. Previously, Hans served as the Chief Executive ... Biography: Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development. ...

Vornamen Per Schambye (2) Maya Schambye (1) Jacob Schambye (1) Hans Schambye (1). Schambye rückwärts ist Eybmahcs Name enthält 6 Buchstaben ...

Nomi Per Schambye (2) Maya Schambye (1) Jacob Schambye (1) Hans Schambye (1). Schambye al contrario è Eybmahcs Il nome è composto di 8 lettere ...

Given names. Per Schambye (2) Maya Schambye (1) Jacob Schambye (1) Hans Schambye (1). Schambye reversed is Eybmahcs Name contains 8 letters ...

· Hans Schambye, President and CEO, commented, "These intermediate results strengthen our belief that GB2064 has the potential to be a disease- ...

Dr. Hans T. Schambye, MD, Ph.D is a Co-Founder of Galecto Biotech AB and serves as Chief Executive Officer. Dr. Schambye served as Chief Executive Officer of...

Entdecke Hans Schambyes 179 Fotos auf Flickr!

Regeringen har i dag nedsat et vækstteam for life science. Kåre Schultz, administrerende direktør for Lundbeck, bliver formand for væks..

... Ulf J. Nilsson, Hakon Leffler, Paul Ford, Anders Pedersen, Lise Gravelle, Susan Tantawi, Hans Schambye, Tariq Sethi, Alison C. MacKinnon.

Case I: What did we do – Rose Pharma (former Gastrotech Pharma) (Hans Schambye, Chairman Board of Directors) Case II: What did we ...

Banner background. Profile. Key People/Management at Dansk Biotek. Alejandra Mørk. Director. Hans Schambye. Director. Henrik Blou. Director. Mai-Britt Zocca.

Place: Copenhagen, Place: Copenhagen ; Date: August 24, For Galecto Biote pS. Date: August 24, ; /s/ Hans Schambye. /s/ Anders H. Pedersen.

Hans Schambye, CEO of Galecto, said “We are excited that the study showed that with intervention with our inhaled small molecule therapy GB0139 in the lungs ...

Bristol-Myers Squibb entered into an agreement with Galecto Biotech AB to gain exclusive rights to TD139, a novel inhaled inhibitor of galectin-3 for the...

vor 5 Tagen · Hans Schambye, CEO. Jon Freve, CFO. + Investors/US, Media/EU. Ashley R. Robinson, Sandya von der Weid.

Den amerikanske medicinalvirksomhed Bristol-Myers Squibb har fået option på at købe det københavner-baserede biotekselskab Galecto Biotech.